• 제목/요약/키워드: Tumors

검색결과 4,736건 처리시간 0.031초

Vascular tumors of the liver: A brief review

  • Sujata Sarangi;Balamurugan Thirunavukkarasu;Sudeep Khera;Selvakumar B;Taruna Yadav
    • 한국간담췌외과학회지
    • /
    • 제27권4호
    • /
    • pp.329-341
    • /
    • 2023
  • Vascular tumors of the liver are mesenchymal lesions from endothelial cells. They range from common benign lesions such as haemangioma, intermediate tumors like Kaposi sarcoma, and perivascular epithelioid cell tumor to malignant tumors such as hepatic epithelioid hemangioendothelioma and hepatic angiosarcoma in adults. Pediatric vascular tumors of the liver also include benign, locally aggressive, borderline, and malignant masses with haemangiomas being the most common benign tumors and epithelioid hemangioendothelioma being an uncommon pediatric malignancy. The list of these lesions is completed by nodular regenerative hyperplasia, solitary fibrous tumour, and hepatic small vessel neoplasms (HSVN). Some of these tumors are uncommon and rare. This review article aimed to enumerate hepatic vascular tumors along with their imaging, histopathology, molecular findings for accurate diagnosis that can result in better management.

Histopathology Analysis of Benign Colorectal Diseases and Colorectal Cancer in Hatyai Hospital, Songkhla, Thailand

  • Kotepui, Manas;Piwkham, Duangjai;Songsri, Apiram;Charoenkijkajorn, Lek
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권4호
    • /
    • pp.2667-2671
    • /
    • 2013
  • Background: Colorectal cancer (CRC) is a major cause of morbidity and mortality in the western world and also ranks as the fifth-leading malignancy and death in Thailand. This study aimed to provide a present outlook of colorectal diseases among Thai patients with special emphasis on CRC in Hatyai, Songkhla, southern Thailand. Materials and Methods: This retrospective study covered ten year data of CRC, benign colorectal tumors and non-colorectal tumors from the Department of Pathology in Hatyai Hospital, Songkhla, Thailand, between years 2003-2012. Incidence rates based on age, gender, ten year incidence trends, and distribution of histopathological characteristics of patients were calculated and demonstrated. Results: Out of 730 biopsies, 100 cases were benign colorectal tumors, 336 were CRC and 294 were non-colorectal tumors. Colorectal tumors (both benign and CRC) (60.1%) were more common than non-colorectal tumors (39.9%). CRC (77.1%) were more common than benign colorectal tumors (32.9%). Colorectal tumors were mainly found in patients aged over sixty whereas non-colorectal and benign colorectal tumors were found in those under sixty (P=0.01). sAmong CRC, adenocarcinoma contributed about 97.3% of all cases with well differentiated tumors being the most frequent (56.9%). Both benign colorectal tumors and CRC were more commonly found in males (63%) than females (37%). The incidence trend of CRC demonstrated increase from 2003-2012. Conclusions: The incidence of CRC increased in Hatyai from 2003-2012. CRC tends to be more common in people older than sixty, thus, screening programs, cost-effective analysis of treatment modalities, and treatment protocols for the elderly should be examined. Proper implementation of preventive measures such as changing lifestyle factors might enhance control of colorectal disease.

주 타액선 종양에 대한 10년 간의 경험 (Major Salivary Glands Tumors:A 10-Year Experience)

  • 공일규;장동엽;정은정;정영호;하정훈;성명훈;김광현
    • 대한두경부종양학회지
    • /
    • 제22권2호
    • /
    • pp.142-146
    • /
    • 2006
  • Background and Objectives : This study reports our clinicopathological experiences of major salivary gland tumors. Materials and Methods : This study included 302 patients with major salivary gland tumors who had got the diagnosis from January 1995 through December 2004. Medical records were reviewed retrospectively. Results : We found 244 benign and 58 malignant major salivary gland tumors. Among 267 parotid tumors, the most common benign parotid tumor was pleomorphic adenoma. Mucoepidermoid carcinoma, adenoid cystic carcinoma, and acinic cell carcinoma were three most common parotid malignancies. Among 33 submandibular gland tumors, 20 cases were benign and 13 were malignant. There were one benign and one malignant sublingual gland tumors. The duration of symptom of submandibular gland tumors was longer than that of parotid tumors. Most patients presented with asymptomatic mass. Seventy-one percent of salivary gland malignancies underwent postoperative radiation therapy. Five-year disease free survival rate of parotid malignant tumors seemed to be higher than that of submandibular one, although there was no statistical significance. Conclusion : Malignancy rate of each salivary gland followed old axiom that it is inversely related with the size of gland. Submandibular gland tumor tends to be delayed to reach diagnosis. Clinicians must be alert about this finding because submandibular gland tumors are known to have poorer prognosis than parotid tumors.

연조직종양의 새로운 WHO 분류를 중심으로: 지방세포종, 섬유모세포성/근육섬유모세포성종, 소위섬유조직구종, 평활근종, 혈관주위종과 근골격종에 대하여 (Adipose Tumor, Fibroblastic/Myofibroblastic Tumors, So-called Fibrohistiocytic Tumors, Smooth Muscle Tumors, Pericytic Tumors and Skeletal Muscle Tumors: An Update Based on the New WHO Soft Tissue Classification)

  • 서경진
    • 대한골관절종양학회지
    • /
    • 제14권1호
    • /
    • pp.1-9
    • /
    • 2008
  • 연조직종양의 이해는 과거 10년 동안에 걸쳐 주요 변화와 더불어 실질적인 진보가 있었고, 이를 바탕으로 연조직종양의 새로운 분류가 WHO에 의해 2002년에 이루어졌다. 이 개정은 이전에 발표와 상당히 다른 내용의 접근을 하였고, 이 작업에 유전학과 분자생물학 그리고 임상분야의 전문가들이 참여하였다. 여기에서는 과거에 알고 있었거나 특성이 알려진 많은 종양을 포함하여 새로운 큰 변화나 작은 변화가 일어난 부분에 대해서 정리를 하였다. 이러한 내용을 연조직종양의 새로운 WHO 분류를 중심으로 지방세포종, 섬유모세포성/근육섬유모세포 성종과 소위섬유조직구종, 평활근종, 혈관주위종과 근골격종을 중심으로, 큰 변화와 작은 변화로 나누어서 설명하고 새롭게 소개되는 병명을 소개하고 정리하였다. 이 새로운 WHO의 연조직종양의 분류를 이해하여, 종양의 진단과 예후의 재현을 용이하게 하는 필수적인 지침으로 사용할 수 있을 것으로 생각된다.

  • PDF

척수 종양 654예의 임상 분석(1973-1999) (Spinal Cord Tumors : An Analysis of 654 Cases(1973-1999))

  • 최우진;정천기;조병규;김현집
    • Journal of Korean Neurosurgical Society
    • /
    • 제30권8호
    • /
    • pp.1004-1012
    • /
    • 2001
  • Objective : The spinal cord tumors(including vertebral tumors) are increasingly diagnosed and operated due to development of refined diagnostic and therapeutic tools. It is necessary to re-evaluate clinical features and surgical results of spinal cord tumors with increasing cases and developing treatment modalities. The authors reviewed the spinal cord tumor cases to evaluate their clinical characteristics. Material and Methods : The retrospective review of 654 cases of spinal cord tumors between 1973 and 1999 was done. The clinical features, pathological analysis and surgical results were analyzed and compared to the literature. The results of the study are analyzed with a more detailed consideration of each of major pathologies : neurogenic tumors, meningeal tumors, neuroepithelial tumors, and metastatic tumors. Results and Conclusion : The spinal cord tumor was most common in the 5th decade of age(145 cases, 22.1%) and 78 cases(11.9%) were found in children under 15 years of age. The ratio of male to female was 1.2 : 1. The pathologic diagnosis was neurogenic tumor in 266 cases(40.7%), neuroepithelial tumor in 131(20.0%), metastatic tumor in 118(18.0%), and meningeal tumor in 94(14.4%) in the order of frequency. The tumor was located most frequently in the thoracic area(36.5%) and in the intradural extramedullary space(38.1%). The most common initial presentation was pain(40.1%) and the mean duration for presentation to operation was 14.8 months. The total or gross total removal was possible in 404 cases(61.7%) and the surgical result on the postoperative one month was recovery or improvement in 424 cases(64.8%), stationary in 188(28.7%), progression in 42(6.4%). As a surgical complication, there was a spinal deformity(12 cases), wound infection(5 cases), aspiration pneumonia(5 cases) etc. Neurogenic tumors and menigiomas showed good surgical results, whereas neuroepithelial tumors(except ependymoma) and metastatic tumors showed relatively poor prognosis.

  • PDF

타액선 종양에서 종양증식 관련인자 발현에 관한 면역조직화학적 연구 (IMMUNOHISTOCHEMICAL STUDY ON EXPRESSION PATTERNS OF TUMOR GROWTH RELATED FACTORS IN SALIVARY GLAND TUMORS)

  • 김한석;김성민;박영욱
    • Maxillofacial Plastic and Reconstructive Surgery
    • /
    • 제29권5호
    • /
    • pp.405-416
    • /
    • 2007
  • Objective : Lots of papers have revealed that tumor growth related factors such as EGF, EGFR, c-erbB-2 play an important role in tumorigenesis and proliferation. These factors are found in most tumors of ectodermal origin. But, documentations of tumor growth related factors on salivary gland tumors were rare. Therefore, we determined expressions of tumor growth related factors; PCNA, p53, EGF, EGFR, cerbB2(HER-2), Maspin, DMBT-1, N-Ras in representative salivary gland tumors. Materials and methods : A few types of salivary tumors were examined by immunohistochemical assays. Each antibody was applied to specimens of tumors. Specimens were composed of 5 pleomorphic adenomas (PA), 3 mucoepidermoid carcinomas (MEC), 2 adenoid cystic carcinomas (ACC) and 2 squamous cell carcinomas (SCC) from 12 patients. One specimen was selected randomly as negative control. For evaluation of staining intensity, each stained sample was divided into 5 grade; no staining, obscure, weak staining, moderate staining, strong staining. Results : Strong expressions of PCNA were found in all tumors except of PA. EGF was expressed strongly in SCC, ACC sequently. But in both PA and MEC, EGF expression was weak. EGFR and c-erbB-2 expression showed similar patterns in all salivary gland tumor tissues. P53 showed weak expression generally in all salivary gland tumors. DMBT-1 was expressed in SCC rather than in ACC or in MEC. N-Ras showed weak expressions in all salivary gland tumors except of squamous cell carcinoma. Conclusion : Taken together, tumor growth related factors were expressed in salivay tumors as well as mucosal squamous cell carcinoma. Especially EGFR and c-erbB-2 could be candidates as diagnostic markers for estimating clinical grade of salivary gland tumors. But further studies with reliable methods will be needed to confirm the results of this study.

Mammary gland tumors in three male dogs

  • Han, Jeong-Hee;Kim, Kyeong-Soo;Kim, Jae-Hoon
    • 대한수의학회지
    • /
    • 제56권4호
    • /
    • pp.229-232
    • /
    • 2016
  • Mammary gland tumors are very rare in male dogs. In this study, four mammary gland tumors from 3 male dogs (2 intact, 1 neutered) were collected from local animal hospitals. The dogs included two purebred Shih Tzu (1 intact, 1 neutered) and one intact purebred Cocker Spaniel. The mean age of dogs with mammary gland tumors was 9 years (5-12 years). Two dogs had a solitary mass, whereas one dog had two mammary masses. Of the four tumor masses, three were observed in the fourth or fifth mammary glands, and one was observed in the third mammary gland. According to histopathologic examinations, all four mammary masses from three dogs were benign tumors including two benign mixed tumors in one case and two complex adenomas. There were no history of obesity, testicular tumors, diabetes, and sex hormonal therapy in any male dogs with mammary tumors. Surgical excision was the only reported treatment for these tumors. No recurrence or metastasis was recorded up to 25 months after surgery.

족부의 종양 (Tumors of the Foot)

  • 신덕섭;박성혁;안종철
    • 대한골관절종양학회지
    • /
    • 제9권1호
    • /
    • pp.69-76
    • /
    • 2003
  • 목적: 족부에 발생하는 종양의 임상적 특성과 병리학적 특성 및 분포 등을 조사하여, 족부 종양을 진단하고 치료하는데 기초 자료를 제공하고자 한다. 대상 및 방법: 족부 종양 환자 141명의 142 종양을 대상으로 하였다. 대상환자들은 모두 조직검사를 통하여 진단이 된 환자들이었다. 대상이 되었던 환자들의 의무기록과 영상 검사들을 후향적으로 검토하여 종양의 역학적 조사와, 임상적 특성과 수술의 방법을 확인하였고, 병리학적 특성을 조사하였다. 종양이 발생 위치는 Kirby 등이 제안한 구역(zone)에 따라 분류하였다. 결과: 여자는 75명이었고 남자는 66명으로 여자가 조금 많았다. 전체 환자들의 평균 나이는 33.2세였다. 양성 연부조직 종양이 68예로 가장 많았고, 양성 골종양이 57예, 악성 연부조직 종양이 12예, 악성 골종양이 5예의 순이었다. 양성 연부조직 종양 중에는 결절종이 36예로 가장 많았고, 양성 골종양 중에서는 조갑하 외골종이 18예, 악성 연부조직 종양 중에서는 편평 상피 세포암이 7예, 악성 골종양으로는 폐암의 전이 병소가 2예였다. 환자들의 임상 증상으로 통증은 악성 골종양 환자들이 가장 높은 비율로 호소하였고, 증상 발현 기간은 양성 연부조직 종양이 가장 길었고, 신경학적 증상은 양성 연부조직 종양에서만 3예가 있었다. 종양의 평균 크기는 악성 골종양이 가장 크고, 양성 골종양이 가장 작았다. 구역별 분포는 전체적으로 5 구역에 59예로 가장 많았고, 4 구역에 10예로 가장 적었으며, 양성 골종양에서는 5 구역, 양성 연부조직 종양에서는 1 구역, 악성 골종양에서는 1, 2 구역, 악성 연부조직 종양에서는 5 구역에서 가장 많았다. 수술 방법으로 병소내 혹은 변연부 절제술, 소파술 혹은 소파술 및 골이식 수술, 족지 절단수술, 슬관절 하 절단술과 사지구제술 등이 있었다. 결론: 족부에 발생하는 종양은 드물고 종류가 다양하면서 대부분(88%) 양성 종양이었으나, 진단 과정에서 환자의 나이, 통증 유무, 증상 발현 기간, 종양의 크기 및 발생 구역 등을 고려하여 악성 종양의 가능성을 배제하지 않음으로써 올바른 치료를 할 수 있을 것으로 사료된다.

  • PDF

Diffusion Weighted Imaging Can Distinguish Benign from Malignant Mediastinal Tumors and Mass Lesions: Comparison with Positron Emission Tomography

  • Usuda, Katsuo;Maeda, Sumiko;Motono, Nozomu;Ueno, Masakatsu;Tanaka, Makoto;Machida, Yuichiro;Matoba, Munetaka;Watanabe, Naoto;Tonami, Hisao;Ueda, Yoshimichi;Sagawa, Motoyasu
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제16권15호
    • /
    • pp.6469-6475
    • /
    • 2015
  • Background: Diffusion-weighted magnetic resonance imaging (DWI) makes it possible to detect malignant tumors based on the diffusion of water molecules. It is uncertain whether DWI is more useful than positron emission tomography-computed tomography (PET-CT) for distinguishing benign from malignant mediastinal tumors and mass lesions. Materials and Methods: Sixteen malignant mediastinal tumors (thymomas 7, thymic cancers 3, malignant lymphomas 3, malignant germ cell tumors 2, and thymic carcinoid 1) and 12 benign mediastinal tumors or mass lesions were assessed in this study. DWI and PET-CT were performed before biopsy or surgery. Results: The apparent diffusion coefficient (ADC) value ($1.51{\pm}0.46{\times}10^{-3}mm^2/sec$) of malignant mediastinal tumors was significantly lower than that ($2.96{\pm}0.86{\times}10^{-3}mm^2/sec$) of benign mediastinal tumors and mass lesions (P<0.0001). Maximum standardized uptake value (SUVmax) ($11.30{\pm}11.22$) of malignant mediastinal tumors was significantly higher than that ($2.53{\pm}3.92$) of benign mediastinal tumors and mass lesions (P=0.0159). Using the optimal cutoff value (OCV) $2.21{\times}10^{-3}mm^2/sec$ for ADC and 2.93 for SUVmax, the sensitivity (100%) by DWI was not significantly higher than that (93.8%) by PET-CT for malignant mediastinal tumors. The specificity (83.3%) by DWI was not significantly higher than that (66.7%) for benign mediastinal tumors and mass lesions. The accuracy (92.9%) by DWI was not significantly higher than that (82.1%) by PET-CT for mediastinal tumors and mass lesions. Conclusions: There was no significant difference between diagnostic capability of DWI and that of PET-CT for distinguishing mediastinal tumors and mass lesions. DWI is useful in distinguishing benign from malignant mediastinal tumors and mass lesions.

Association of Poor Prognosis Subtypes of Breast Cancer with Estrogen Receptor Alpha Methylation in Iranian Women

  • Izadi, Pantea;Noruzinia, Mehrdad;Fereidooni, Foruzandeh;Nateghi, Mohammad Reza
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제13권8호
    • /
    • pp.4113-4117
    • /
    • 2012
  • Breast cancer is a prevalent heterogeneous malignant disease. Gene expression profiling by DNA microarray can classify breast tumors into five different molecular subtypes: luminal A, luminal B, HER-2, basal and normal-like which have differing prognosis. Recently it has been shown that immunohistochemistry (IHC) markers including estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (Her2), can divide tumors to main subtypes: luminal A (ER+; PR+/-; HER-2-), luminal B (ER+;PR+/-; HER-2+), basal-like (ER-;PR-;HER2-) and Her2+ (ER-; PR-; HER-2+). Some subtypes such as basal-like subtype have been characterized by poor prognosis and reduced overall survival. Due to the importance of the ER signaling pathway in mammary cell proliferation; it appears that epigenetic changes in the $ER{\alpha}$ gene as a central component of this pathway, may contribute to prognostic prediction. Thus this study aimed to clarify the correlation of different IHC-based subtypes of breast tumors with $ER{\alpha}$ methylation in Iranian breast cancer patients. For this purpose one hundred fresh breast tumors obtained by surgical resection underwent DNA extraction for assessment of their ER methylation status by methylation specific PCR (MSP). These tumors were classified into main subtypes according to IHC markers and data were collected on pathological features of the patients. $ER{\alpha}$ methylation was found in 25 of 28 (89.3%) basal tumors, 21 of 24 (87.5%) Her2+ tumors, 18 of 34 (52.9%) luminal A tumors and 7 of 14 (50%) luminal B tumors. A strong correlation was found between $ER{\alpha}$ methylation and poor prognosis tumor subtypes (basal and Her2+) in patients (P<0.001). Our findings show that $ER{\alpha}$ methylation is correlated with poor prognosis subtypes of breast tumors in Iranian patients and may play an important role in pathogenesis of the more aggressive breast tumors.